Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check20 days agoChange DetectedA notice regarding potential delays and outdated information due to a lapse in government funding has been removed.SummaryDifference0.4%

- Check34 days agoChange DetectedBoth screenshots depict the same ClinicalTrials.gov record for NCT02564380, with no changes to core information like title, sponsor, location, eligibility criteria, or outcomes; any differences are limited to layout/visual formatting. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedMajor update: page now includes a funding-related operating status notice and announces version 3.2.0, replacing v3.1.0.SummaryDifference3%

- Check69 days agoChange DetectedUpdate to version v3.1.0; removal of several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and archival of v3.0.2.SummaryDifference0.5%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.